Glycogen synthase kinase 3β (GSK3β) mediates 6-hydroxydopamine-induced neuronal death

被引:260
作者
Chen, G
Bower, KA
Ma, CL
Fang, SY
Thiele, CJ
Luo, J [1 ]
机构
[1] W Virginia Univ, Sch Med, Robert C Byrd Hlth Sci Ctr, Dept Microbiol Immunol & Cell Biol, Morgantown, WV 26506 USA
[2] Univ Maryland, Inst Biotechnol, Ctr Med Biotechnol, Baltimore, MD 21201 USA
[3] NCI, Pediat Oncol Branch, Bethesda, MD 20892 USA
[4] Chinese Acad Sci, SIBS, Inst Nutr Sci, Shanghai, Peoples R China
关键词
apoptosis; caspases; endoplasmic reticulum stress; neurodegeneration; neurotrophins;
D O I
10.1096/fj.04-1551fje
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The causes of sporadic Parkinson's disease (PD) are poorly understood. 6-Hydroxydopamine (6-OHDA), a PD mimetic, is widely used to model this neurodegenerative disorder in vitro and in vivo; however, the underlying mechanisms remain incompletely elucidated. We demonstrate here that 6-OHDA evoked endoplasmic reticulum ( ER) stress, which was characterized by an up-regulation in the expression of GRP78 and GADD153 (Chop), cleavage of procaspase-12, and phosphorylation of eukaryotic initiation factor-2 alpha in a human dopaminergic neuronal cell line (SH-SY5Y) and cultured rat cerebellar granule neurons (CGNs). Glycogen synthase kinase-3 beta (GSK3beta) responds to ER stress, and its activity is regulated by phosphorylation. 6-OHDA significantly inhibited phosphorylation of GSK3beta at Ser9, whereas it induced hyperphosphorylation of Tyr216 with little effect on GSK3beta expression in SH-SY5Y cells and PC12 cells (a rat dopamine cell line), as well as CGNs. Furthermore, 6-OHDA decreased the expression of cyclin D1, a substrate of GSK3beta, and dephosphorylated Akt, the upstream signaling component of GSK3beta. Protein phosphatase 2A (PP2A), an ER stress-responsive phosphatase, was involved in 6-OHDA-induced GSK3beta dephosphorylation (Ser9). Blocking GSK3beta activity by selective inhibitors ( lithium, TDZD-8, and L803-mts) prevented 6-OHDA-induced cleavage of caspase-3 and poly(ADP-ribose) polymerase (PARP), DNA fragmentations and cell death. With a tetracycline (Tet)-controlled TrkB inducible system, we demonstrated that activation of TrkB in SH-SY5Y cells alleviated 6-OHDA-induced GSK3beta dephosphorylation (Ser9) and ameliorated 6-OHDA neurotoxicity. TrkB activation also protected CGNs against 6-OHDA-induced damage. Although antioxidants also offered neuroprotection, they had little effect on 6-OHDA-induced GSK3beta activation. These results suggest that GSK3beta is a critical intermediate in pro-apoptotic signaling cascades that are associated with neurodegenerative diseases, thus providing a potential target site amenable to pharmacological intervention.
引用
收藏
页码:1162 / +
页数:26
相关论文
共 88 条
  • [1] Activation and phosphorylation of a pleckstrin homology domain containing protein kinase (RAC-PK/PKB) promoted by serum and protein phosphatase inhibitors
    Andjelkovic, M
    Jakubowicz, T
    Cron, P
    Ming, XF
    Han, JW
    Hemmings, BA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (12) : 5699 - 5704
  • [2] THE DETERMINATION OF HYDROXYDOPAMINES AND OTHER TRACE AMINES IN THE URINE OF PARKINSONIAN-PATIENTS AND NORMAL CONTROLS
    ANDREW, R
    WATSON, DG
    BEST, SA
    MIDGLEY, JM
    WENLONG, H
    PETTY, RKH
    [J]. NEUROCHEMICAL RESEARCH, 1993, 18 (11) : 1175 - 1177
  • [3] trkB messenger RNA expression in normal human brain and in the substantia nigra of Parkinsonian patients:: An in situ hybridization study
    Benisty, S
    Boissiere, F
    Faucheux, B
    Agid, Y
    Hirsch, EC
    [J]. NEUROSCIENCE, 1998, 86 (03) : 813 - 826
  • [4] Betarbet R, 2002, BRAIN PATHOL, V12, P499
  • [5] GSK3β signalling:: Casting a wide net in Alzheimer's disease
    Bhat, RV
    Budd, SL
    [J]. NEUROSIGNALS, 2002, 11 (05) : 251 - 261
  • [6] Proapoptotic stimuli induce nuclear accumulation of glycogen synthase kinase-3β
    Bijur, GN
    Jope, RS
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (40) : 37436 - 37442
  • [7] Choi WS, 1999, J NEUROSCI RES, V57, P86, DOI 10.1002/(SICI)1097-4547(19990701)57:1<86::AID-JNR9>3.3.CO
  • [8] 2-5
  • [9] COHEN G, 1974, J BIOL CHEM, V249, P2447
  • [10] Courtney MJ, 1997, J NEUROSCI, V17, P4201